Are enterococci playing a role in postoperative peritonitis in critically ill patients?

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 7, 2012, Pages 1479-1485

  Seguin, P ^a,b,c,e   Brianchon, C ^b   Launey, Y ^a,b,c   Laviolle, B ^a,c,d   Nesseler, N ^a,b,c   Donnio, P Y ^a   Malledant, Y ^a,b,c  

^a RENNES UNIVERSITY HOSPITAL   (France)

^b Univ Rennes   (France)

^c UNIVERSITÉ DE RENNES 1   (France)

^d INSERM   (France)

^e PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFEPIME; GENTAMICIN; METRONIDAZOLE; PENICILLIN G; TIMENTIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ABDOMINAL ABSCESS; ABDOMINAL SURGERY; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL PERITONITIS; CONVALESCENCE; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FEMALE; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE; LAPAROTOMY; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PREDICTION; PRIORITY JOURNAL; REOPERATION; SURGICAL DRAINAGE; SURGICAL MORTALITY; ADOLESCENT; AGED; CRITICAL ILLNESS; DRUG UTILIZATION; GRAM POSITIVE INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MORTALITY; PERITONITIS; PROSPECTIVE STUDY; STATISTICS; SURVIVAL;

ABDOMINAL ABSCESS; ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CRITICAL ILLNESS; DRUG UTILIZATION; ENTEROCOCCUS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; PERITONITIS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84865583125     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1467-8     Document Type: Article

References (22)

1. Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, O'Neill PJ, Chow AW, Dellinger EP, Eachempati SR, Gorbach S, Hilfiker M, May AK, Nathens AB, Sawyer RG, Bartlett JG (2010) Diagnosis and management of complicated intra-abdominal infection in adults and children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 50(2):133-164
2. Augustin P, Kermarrec N,Muller-Serieys C, Lasocki S, Chosidow D, Marmuse JP, Valin N, Desmonts JM, Montravers P (2010) Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis. Crit Care 14(1):R20
3. Roehrborn A, Thomas L, Potreck O, Ebener C, Ohmann C, Goretzki PE, Roher HD (2001) The microbiology of postoperative peritonitis. Clin Infect Dis 33(9):1513-1519
4. Seguin P, Fedun Y, Laviolle B, Nesseler N, Donnio PY, Malledant Y (2010) Risk factors for multidrug-resistant bacteria in patients with post-operative peritonitis requiring intensive care. J Antimicrob Chemother 65(2):342-346
5. Seguin P, Laviolle B, Chanavaz C, Donnio PY, Gautier-Lerestif AL, Campion JP, Malledant Y (2006) Factors associated with multidrug-resistant bacteria in secondary peritonitis: Impact on antibiotic therapy. Clin Microbiol Infect 12(10):980-985
6. Dupont H, Carbon C, Carlet J (2000) Monotherapy with a broadspectrum betalactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: A multicenter randomized controlled trial. The Severe Generalized Peritonitis Study Group. Antimicrob Agents Chemother 44(8):2028-2033
7. Riché FC, Dray X, Laisne MJ, Mateo J, Raskine L, Sanson-Le Pors MJ, Payen D, Valleur P, Cholley BP (2009) Factors associated with septic shock and mortality in generalized peritonitis: Comparison between community-acquired and postoperative peritonitis. Crit Care 13(3):R99
8. Burnett RJ, Haverstock DC, Dellinger EP, Reinhart HH, Bohnen JM, Rotstein OD, Vogel SB, Solomkin JS (1995) Definition of the role of enterococcus in intraabdominal infection: Analysis of a prospective randomized trial. Surgery 118(4):716-721; discussion 721-713
9. Mazuski JE, Sawyer RG, Nathens AB, DiPiro JT, Schein M, Kudsk KA, Yowler C (2002) The Surgical Infection Society guidelines on antimicrobial therapy for intraabdominal infections: Evidence for the recommendations. Surg Infect (Larchmt) 3(3):175-233
10. Cercenado E, Torroba L, Canton R, Martinez-Martinez L, Chaves F, Garcia-Rodriguez JA, Lopez-Garcia C, Aguilar L, Garcia-Rey C, Garcia-Escribano N, Bouza E (2010) Multicenter study evaluating the role of enterococci in secondary bacterial peritonitis. J Clin Microbiol 48(2):456-459
11. Sitges-Serra A, Lopez MJ, Girvent M, Almirall S, Sancho JJ (2002) Postoperative enterococcal infection after treatment of complicated intra-abdominal sepsis. Br J Surg 89(3):361-367
12. Sotto A, Lefrant JY, Fabbro-Peray P, Muller L, Tafuri J, Navarro F, Prudhomme M, De La Coussaye JE (2002) Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis. J Antimicrob Chemother 50(4):569-576
13. Bone RC, Sibbald WJ, Sprung CL (1992) The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 101 (6):1481-1483
14. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R (1994) The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149(3 Pt 1):818-824
15. Bellomo R, Kellum J, Ronco C (2001) Acute renal failure: Time for consensus. Intensive Care Med 27(11):1685-1688
16. Matlow AG, Bohnen JM, Nohr C, Christou N, Meakins J (1989) Pathogenicity of enterococci in a rat model of fecal peritonitis. J Infect Dis 160(1):142-145
17. Montravers P, Andremont A, Massias L, Carbon C (1994) Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis. J Infect Dis 169 (4):821-830
18. Onderdonk AB, Bartlett JG, Louie T, Sullivan-Seigler N, Gorbach SL (1976) Microbial synergy in experimental intra-abdominal abscess. Infect Immun 13(1):22-26
19. Weinstein WM, Onderdonk AB, Bartlett JG, Louie TJ, Gorbach SL (1975) Antimicrobial therapy of experimental intraabdominal sepsis. J Infect Dis 132(3):282-286
20. Cohn SM, Lipsett PA, Buchman TG, Cheadle WG, Milsom JW, O'Marro S, Yellin AE, Jungerwirth S, Rochefort EV, Haverstock DC, Kowalsky SF (2000) Comparison of intravenous/oral ciprofloxacin plus metronidazole versus piperacillin/ tazobactam in the treatment of complicated intraabdominal infections. Ann Surg 232 (2):254-262
21. Ohlin B, Cederberg A, Forssell H, Solhaug JH, Tveit E (1999) Piperacillin/tazobactam compared with cefuroxime/metronidazole in the treatment of intra-abdominal infections. Eur J Surg 165 (9):875-884
22. Solomkin JS, Yellin AE, Rotstein OD, Christou NV, Dellinger EP, Tellado JM, Malafaia O, Fernandez A, Choe KA, Carides A, Satishchandran V, Teppler H (2003) Ertapenem versus piperacillin/ tazobactam in the treatment of complicated intraabdominal infections: Results of a double-blind, randomized comparative phase III trial. Ann Surg 237(2):235-245